Table 5 Sensitivity and specificity of the method used.
| Â | Hospital N.1 | Hospital N.2 | Hospital N.3 | |||
|---|---|---|---|---|---|---|
| Â | Sensibility | Specificity | Sensibility | Specificity | Sensibility | Specificity |
1. Aspirin prescribed at discharge | 96.1% | 100.0% | 99.7% | 100.0% | 97.8% | 100.0% |
2. Beta-blocker prescribed at discharge | 95.7% | 100.0% | 97.6% | 100.0% | 100.0% | 100.0% |
3. Adult smoking cessation advice Counseling | 100.0% (68.9% for the research of Former smokers) | 100.0% | Â | Â | 100.0% (100.0% for the research of former smokers) | 100.0% |
4. LDL cholesterol assessment | 100.0% | 100.0% | 100.0% | 100.0% | 33.3% | 100.0% |
5. Lipid lowering therapy at discharge | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
6. Inpatient mortality | 100.0% | 100.0% | Â | Â | Â | Â |
7. Evaluation of left ventricular systolic (LVS) function (LVF Assessment) | 99.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
8. ACEI or ARB for left ventricular systolic dysfunction (LVSD) | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
9. Adult smoking cessation advice counseling | 96.3% (94.5% for the research of former smokers) | 100.0% | Â | Â | 100.0% (73.3% for the research of former smokers) | 100.0% |
10. Thrombolytic therapy administered | 100.0% | 100.0% | 100.0% | 99.5% | 100.0% | 100.0% |
11. Discharged on cholesterol reducing medication | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
12. Smoking cessation advice/counseling | 100.0% (100.0% for the research of former smokers) | 100.0% | Â | Â | 100.0% | 97.6% (100.0% for the research of former smokers) |
13. Hip or Knee replacement Patients with Recommended Venous Thromboembolism (VTE) Prophylaxis Ordered | 99.4% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |